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Abstract
Epidemiological and clinical studies have shown that dietary intake of carotenoid-rich
fruits and vegetables is positively correlated with reduction in age-related eye diseases,
atherosclerosis, certain cancers and chronic diseases. Carotenoids consist of unique
chemical characteristics and are highly vulnerable to structural modifications, leading
to the formation of various derivatives under physiological conditions. The identifica-
tion  of  these  molecules  is  necessary  before  addressing  their  biological  functions.
Carotenoid  metabolomics  is  believed  to  be  highly  complex  to  fingerprint  due  to
instability and interference with complex biological matrices. Noteworthy, progress has
been  made  in  understanding  carotenoid  metabolism  or  its  biotransformation  in
biological samples. In this regard, the chapter highlights the concept of metabolomics
and their related bio-analytical techniques pertaining to the detection of carotenoids
and their derived products to elucidate their bio-transformation on targeted biological
functions. Further, this chapter highlights the various hyphenated analytical tools and
their optimization.
Keywords: metabolomics, hyphenated technique, bio-functionality, metabolites
1. Introduction
Considerable research has made in understanding the potential role of carotenoids in plants
and  animals.  Carotenoids  are  tetra-terpenoids,  a  group  of  natural  compounds,  found
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predominantly in photosynthesizing organisms such as green plants, algae and some bacteria
[1]. There are over 750 carotenoids identified in nature; among them, major carotenoids like
α-carotene, β-carotene, lycopene, lutein, zeaxanthin, astaxanthin, fucoxanthin and β-cryptox-
anthin are well explored. In plants, carotenoids and their derivatives (apo-carotenoids) are
believed to involve in photosynthesis,  photo-protection,  the precursor for hormones and
production of aroma and flavor [2]. The diversity of carotenoids in nature is formed from the
common biosynthetic pathway. The exploration of each distinctive carotenoid pigment from
various dietary sources or non-dietary sources is the milestone in carotenoids biochemistry
and metabolism. In animals and human, dietary ingestion is the only source of carotenoids
obtained from plants (vegetables and fruits) or animals (meat, fish and poultry products) or
other nutraceuticals sources. They are categorized based on biological functions as provitamin
A or non-provitamin A carotenoids. Further, they classified as carotenes (β-carotene and
lycopene) and xanthophylls with epoxy- (violaxanthin, neoxanthin, fucoxanthin), hydroxy-
(lutein and zeaxanthin), keto- (astaxanthin and canthaxanthin) and methoxy- (spirilloxanthin)
functional  groups.  In  plants  and  certain  microorganisms,  under  various  environmental
conditions, the biotransformation of carotenoids occurs as a necessary adaptation. Carotenoids
research is an active area of research due to the characteristics of different chemical nature
with unique biological function [3]. Epidemiological and clinical trials have correlated that
consumption of carotenoids rich fruits and green vegetables decreases vitamin A deficiency
problems, cancer, cardiovascular diseases and age-related macular degeneration [4]. Although
diversified carotenoids with unique characteristics structures exist  in nature,  the relation
between structure function needs to explore by developing appropriate analytical protocols
and techniques. Only a few carotenoids are studied and detailed from past three decades, due
to their presence in common dietary sources and human serum and tissues. Many of the
bioactive compounds execute their function either by intact or by its derivatives [5, 6]. In many
cases, carotenoids daughter molecules exist in nature as a secondary compound, or they
possibly formed over series of reaction that occurs in physiological condition [7]. Carotenoids
consist of long polyene chain with series of conjugated double bonds and functional groups
that make them highly reactive. Thus, carotenoids are more prone to various modifications
such  as  hydrogenation,  dehydrogenation,  double-bond  migration,  chain  shortening  or
extension, rearrangement, isomerization, oxidation or combinations of these processes under
different conditions.  Apart  from these,  carotenoid metabolites may also form due to the
presence of enzymes monooxygenase, cycloxygenase and dioxygenase [8]. Investigation on
β-carotene metabolism and their conversion to vital active molecules, that is, retinyl palmitate,
retinal, retinoic acids and apo-carotenoids, has made a greater contribution to the concept of
metabolomics. Further, these molecules augmented with cellular function on vision, growth,
immune response and related chronic health problems. With this discovery, subsequently
many notable researchers worked on other non-provitamin A carotenoids and succeeded
partly in the identification of bioactive metabolites in vivo.  Therefore,  metabolomics has
attracted and motivated in an identification of carotenoid bioactive metabolites. In continua-
tion, several studies revealed the potential role of carotenoid metabolite or oxidative products
in vitro and in vivo and supported the concept that biological functions mediated through
their metabolites [6–9]. With this background, we highlight the possible biotransformation of
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carotenoids (β-carotene, lycopene, lutein, astaxanthin, fucoxanthin and other carotenoids) and
the  related  analytical  techniques  used  for  their  determination.  Also,  biofuctionality  of
carotenoids metabolites discussed. Further, this chapter details the improvement of analytical
techniques  and their  hyphenation for  evaluation of  carotenoids metabolite  (beneficial  or
harmful effect). The advancement in analytical tools and the discovery of unknown carote-
noids metabolites broaden the scope of carotenoids research. Hence, omics instruments and
their methods perform untargeted and targeted profiling of carotenoids in foods and human
samples. Apart from these, this chapter also emphasizes on the suitability and optimization
of analytical methods to determine carotenoid metabolites.
2. Biotransformation of carotenoids
Even though more than 750 carotenoids are identified and predicted in the natural source, only
a few carotenoids (β-carotene, lycopene, lutein, astaxanthin, fucoxanthin, canthaxanthin)
addressed by using routine analytical techniques. Presently, carotenoids research is mainly
focused on the analysis of dietary carotenoids and linked to biological functions. Since
carotenoids are unstable molecules, it undergoes various modifications (discussed elsewhere),
and hence, it is challenging to analyze such carotenoids or its metabolites. β-Carotene metab-
olites such as retinol, retinal and retinoic acid are studied extensively due to its significance in
human health. Therefore, creating an awareness to study the metabolism of carotenoids and
their bio-functions is currently warranted. The carotenoid metabolites may be involved in
differential gene expression, cell-to-cell communication and cell differentiation. Furthermore,
it is interesting to address the molecular interaction of carotenoids metabolites with free
radicals, protein and lipids at cellular levels. Studies also show that carotenoids oxidative
products may be involved in oxidative stress and act as pro-oxidant [10]. The identification of
oxidative metabolites is considered to be more important before addressing their biological
activity. Hence, rapid and sensitive analytical techniques are given priority. The bioconversion
of major carotenoids such as β-carotene, lycopene, lutein, astaxanthin and fucoxanthin is
discussed in this section.
2.1. Hydrocarbon carotenoids
β-Carotene is the most abundant provitamin A carotenoid found in human diet and tissues.
It exerts a beneficial function in mammals, including humans, due to its ability to convert to
vitamin A. Even though β-carotene considered as a safer form of vitamin A, under circum-
stances detrimental effects also ascribed [11]. A better understanding metabolism of the β-
carotene and their derivatives of (retinoids) are still needed to unequivocally discriminate the
beneficial or detrimental effects under various physiological conditions and thus enable the
formulation of adequate dietary recommendations for different age groups of individuals.
Symmetric oxidative cleavage of β-carotene by the enzyme β-carotene-15, 15′-monooxygenase
(BCMO1) generates two molecules of retinaldehyde, and these molecules further oxidized to
form retinoic acids by aldehyde dehydrogenase. The oxidation of retinoic acid conversion into
more polar compound 4-oxo retinoic acid by cytochrome P450 enzymes is believed to be
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transcriptionally inactive. Alternatively, different forms of alcohol dehydrogenase and a
variety of retinol dehydrogenases reduce retinaldehyde to retinol. Subsequently, these
molecules further get esterified into retinyl esters by the enzyme lecithin retinol acyltransfer-
ase. Also, apo-carotenals can be generated by eccentric cleavage of β-carotene. The cleavage
at the 9′, 10′ double bond is catalyzed by β-carotene 9′, 10′-oxygenase 2 (CMO II) and leads to
the formation of β-apo-10′-carotenal and β-ionone. Apo-carotenals are ultimately converted
into one molecule of retinaldehyde, and the mechanism of this conversion is not completely
elucidated [12].
Figure 1. Molecular structures of hydrocarbon carotenoids and their metabolites.
Lycopene is another major hydrocarbon carotenoid extensively studied due to its potential
role in the reduction in certain chronic diseases including cancer and cardiovascular disease.
Recently, metabolism of lycopene has made a greater insight into the biological role of its
derivates. These observations raised an important question about the effect of lycopene on
various cellular functions and signaling pathways are a result of the direct actions of intact
lycopene or its derivatives. Considerable efforts have been expended to identify its biological
and physiochemical properties. β-Carotene and lycopene have the same molecular mass and
chemical formula, yet lycopene is an open-polyene chain lacking the β-ionone ring structure.
The metabolism of β-carotene studied extensively, but biological activities of lycopene are not
detailed. Derivates of lycopene formed due to shortening the carbon chain by removal of
fragments from one or both the ends. Recent studies have shown that BCMO II enzyme
catalyzes lycopene eccentrically to form apo-10-carotenoids. Cleavage of cis-lycopene by BCO
II may occur at either 9, 10 or 9′, 10′ double bond to produce apo-10′-lycopenal, which can be
oxidized to apo-10′-lycopenoic acid or reduced to apo-10′-lycopenol. Lycopene metabolites,
including apo-6-, apo-8′-, apo-10′-, apo-12′- and apo-14′-lycopenal, were detected in the plasma
of humans [13]. However, the identification of cleaved lycopene metabolites in vivo is
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challenging. Previously, Khachik et al. [9] identified a group of lycopene oxidative products,
2,6-cyclolycopene-1,5-diol in human serum and tissues. In animal studies, several metabolites
were detected in lung tissue of lycopene-supplemented ferrets. The intermediate primary
cleavage product apo-10′-lycopenal could be either reduced apo-10-lycopenol or oxidized to
apo-10′-lycopenoic acid. The apo-10′-lycopenal was further converted into apo-10′-lycopenoic
acid in the presence of NAD+. Similarly in presence of NADH lycopene was converted into
both apo-10′-lycopenoic acid and apo-10′-lycopenol [14]. Gajic et al. [15] reported apo-8′- and
apo-12′-lycopenal as well as other unidentified polar metabolites of lycopene in the liver of
rats when supplemented with lycopene-rich diet. Interestingly, a recent study indicated that
apo-10′- and apo-14′-lycopenoic acid have a remarkable ability to upregulate BCO II expres-
sion [16]. These results showed that lycopene converted to apo-10′-lycopenoids in mammalian
tissues both in vitro and in vivo. These observations presumed that lycopene metabolites play
an important biological functions related to human health. The molecular structures of
hydrocarbon carotenoids and their metabolites are shown in Figure 1.
2.2. Hydroxyl carotenoids
Lutein is one of the major xanthophylls present in green leafy vegetables. Lutein and its isomer
zeaxanthin selectively accumulated in the macula of the human retina. They are recognized as
antioxidants and as blue light filters [17] to protect the eyes from sunlight exposure and other
lifestyle-related oxidative stress, which can lead to age-related macular degeneration and
cataracts. Khachik et al. [9] identified lutein metabolites in human tissues such as plasma, milk,
liver and retina. Yonekura et al. [18] observed remarkable accumulation of lutein metabolites,
3′-Hydroxy-ε,ε-caroten-3-one along with ε,ε-carotene-3,3′-dione in the plasma, liver, kidney
and adipose tissues of mice fed with lutein. Further, findings indicated that mice actively
convert lutein to keto-carotenoids by oxidizing the secondary hydroxyl group. 3′-oxolutein is
the metabolite of lutein detected in human plasma and retina [19]. Similarly, 3′-epilutein
identified in human retina and presumed that this product might form by a reduction of 3′-
oxolutein from lutein. Other lutein derivatives like meso-zeaxanthin detected only in the retina
and formed due to double-bond migration from lutein [20]. The dehydration products of lutein
such as, 3-hydroxy-3′, 4′-didehydro-β,γ-carotene and 3-hydroxy-2′,3′-didehydro-β,ε-carotene
may be formed non-enzymatically in stomach under acidic conditions [9]. Also, studies
demonstrated and indicated the cleavage reaction of xanthophylls occurred in mammals by
BCO II by cleaving double bond at C-9′ and C-10′ of xanthophylls [21].
2.3. Epoxy- and keto-carotenoids
The fucoxanthin is a marine carotenoid found in brown seaweeds, macroalgae and diatoms,
with biological properties. The bioconversion of fucoxanthin to fucoxanthinol and amarou-
ciaxanthin A was found in the plasma and liver of mice fed with fucoxanthin, whereas
fucoxanthin was not detected [22]. Fucoxanthinol hydrolyzed from fucoxanthin in the
intestinal tract, circulated in the body and then oxidatively converted into amarouciaxanthin
A. The conversion of fucoxanthinol into amarouciaxanthin A found in human hepatoma
HepG2 cells. Moreover, oxidative conversion of xanthophylls in mouse liver microsomal
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fractions required NAD+ as a co-factor, and this result demonstrates the metabolic conversion
of the 3-hydroxyl end group at the level of enzyme reaction [23].
Figure 2. Molecular structures of hydroxyl-, epoxy- and keto-carotenoids and their metabolites.
Astaxanthin (ASTX) is a major keto-carotenoid metabolized into 3-hydroxy-4-oxo-β-ionone
and 3-hydroxy-4-oxo-7,8-dihydro-β-ionone in primary rat hepatocytes [24]. However,
enzymes involved in the synthesis of these metabolites and their potential biological functions
are not elucidated. However, ASTX incubated with microsomes containing cytochrome P450
(CYPs) did not generate ASTX metabolites and induction of CYP activity in hepatocytes [25].
Therefore, the CYPs enzymes are not responsible for the production of ASTX metabolites.
Hence, investigation on ASTX metabolites and their metabolism needs to explore. However,
there are no detailed in vivo studies available on astaxanthin metabolites except isomers
detected in human serum samples [26]. Canthaxanthin, (4,4′-diketo-β,β-carotene), is a keto-
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carotenoid found in green algae, crustaceans and certain microorganism. This pigment also
used as poultry feed to extend the dominant pigments in the skin and egg yolk of chickens.
Analysis of tissues from chicks revealed that a portion of canthaxanthin reduced to 4-hydrox-
yechinenone (4-hydroxy-4′-keto-β,β-carotene) and iso-zeaxanthin (4,4′-dihydroxy-β,β-
carotene). Ratio of canthaxanthin to metabolites depends on type of tissue, but in general
metabolites concentrated in the skin [27]. The molecular structure of hydroxyl-, epoxy- and
keto-carotenoids and their metabolites is shown in Figure 2.
3. Sample preparation for carotenoids and their metabolites
Biological samples used for analysis of carotenoid and their metabolites need to store in −80°C
under argon or nitrogen gas to prevent carotenoids deterioration. Before analysis, the tissues
samples thawed at room temperature before homogenization using suitable solvents, and then,
organic phase collected after vortexing and centrifugation. To this appropriate amount of
anhydrous, sodium sulfate should be added to remove traces of moisture. The organic phase
evaporated with argon or nitrogen gas, and the extract was reconstituted in mobile phase and
injected into the LC/MS/MS equipment. Other than the sample preparation adequate care
should be taken to avoid light, heat and exposure to atmospheric oxygen, and the high quality
solvents used for extraction and analysis, proper storage of samples under inert conditions,
addition of antioxidants and completion of analysis within short run time applied with
sophisticated instruments.
4. Analysis of carotenoids and their isomers, cleavage products/oxidation
products or metabolites in food and biological samples
HPLC with C18 and C30 stationary phases either with reverse phase or normal phase used
extensively for the analysis of a diverse group of carotenoids in various natural sources in-
cluding food and biological samples [28, 29]. In general, the separation and resolution of
carotenoids are better with gradient than isocratic solvents system. However, these methods
require higher analysis time and solvent consumption. Further, these conditions and sta-
tionary phase were successfully employed in the analysis of carotenoids and their isomers
or/and related derived products in biological fluids and tissues samples [30, 31]. Others
have attempted and identified several types of carotenoids and their metabolites/oxidative
products by employing gas chromatography and mass spectrometry. Stratton et al. [32]
determined β-carotene oxidation products as β-ionone, β-apo-l4′-carotenal, β-apo-10′-
carotenal, β-apo-8′-carotenal and β-carotene 5,8-endoperoxide by using RP-HPLC and GC-
MS. Wyss and Bucheli [33] developed an HPLC method with automated column switching
for the simultaneous determination of endogenous levels of 13-cis-retinoic acid, all-trans-
retinoic acid and their 4-oxo metabolites in human and animals tissue samples. Khachik et
al. [9] separated, identified, quantified and compared 34 carotenoids, including 13 geomet-
rical isomers and 8 metabolites in breast milk and serum of lactating mothers by HPLC-
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PDA-MS. Wolz et al. [24] investigated the astaxanthin metabolites in primary cultures of rat
hepatocytes by GC-MS. Siems et al. [34] demonstrated the oxidation products of β-carotene
by using capillary gas-liquid chromatography and HPLC. The method developed was line-
ar in the range of 0.3–100 ng/mL with a lower quantification limit. Kim et al. [35] isolated
and analyzed auto-oxidation products of lycopene by GC-MS. Subsequently, Bernstein et al.
[36] identified and quantified the dietary lutein and their geometrical (E/Z) isomers and re-
lated metabolites by HPLC in tissues of the human eye. Dachtler et al. [37] identified carote-
noid stereoisomers in spinach and human retina samples by using HPLC online coupled to
mass spectrometry and nuclear magnetic resonance spectroscopy. Aust et al. [38] have re-
ported lycopene oxidative product 2,7,11-trimethyltetradecahexaene-1,14-dial by using GC-
MS. Sommerburg et al. [39] separated and identified 5,6-epoxi-β-ionone, ionene, β-
cyclocitral, β-ionone, dihydroactinidiolide and 4-oxo-β-ionone as major cleavage products
of β-carotene mediated by hypochlorous acid using GC-MS.
Simultaneously from the late 2000 s, spectroscopic and mass spectrometric techniques have
being used for qualitative and quantitative analysis for structurally different carotenoids and
their derived products. The carotenoid analysis is done by using different ionization modes
such as matrix-assisted laser desorption/ionization (MALDI), electrospray (ESI), atmospheric
pressure chemical ionization (APCI) and atmospheric pressure photoionization (APPI). These
methods are employed successfully to target the mass with better ionization and high resolu-
tion for the identification of broad range of natural organic molecules including carotenoids
[40–42]. Further, this application is extended to explore several metabolites and oxidative
products of carotenoids in rodents and human biological samples [18, 43–45]. Initially, van
Breemen [46] developed an APCI-LC-MS method and analyzed all-trans-retinol and all-trans-
retinyl palmitate with the lower limit of detection (LOD) of 34 fmoles/μL and 36 fmoles/μL
(on-column), and limit of quantitation (LOQ) was 500 fmoles/μl and 250 fmoles/μl (on-
column), respectively. Later, Zhu et al. [47] developed LC/APCI-MS a negative ion mode for
the measurement of labeled and unlabeled β-carotene in human serum and feces to demon-
strate bioefficacy of orally administered β-carotene, and the limit of detection of 0.25 pmol (on
injection of 20 μL of 0.0125 μM β-carotene) and LOQ was 1.0 pmol (on the injection of 20 μL
of 0.050 μM β-carotene) with the linear range of 1.1–2179 pmoles on-column. Further, they
believed that linear range with low LOD and LOQ facilitated sensitive and selective analysis
of provitamin A carotenoids. Fraser et al. [40] used MALDI/TOF-MS to detect and quantify
plant carotenoids, and other metabolites (m/z) in complex biological systems. Schäffer et al.
[48] validated RP-HPLC-DAD method for simultaneous quantification of retinol, retinyl esters,
tocopherols and selected carotenoids in the lung, liver and plasma of various animal samples.
Würtinger and Oberacher [49] demonstrated influence of analytical parameters like constitu-
ents of mobile phase, including the modifiers added (acids, bases, dopants, metals and salts)
and other experimental conditions (collision energy, flow collision gas, temperatures, etc.) on
the ionization of the analyses (e.g., ESI, APCI, APPI, FAB). Consequently, Giuffrida et al. [50]
for the first time analyzed and identified 52 carotenoids among the various cultivars of
Capsicum using HPLC-DAD-APCI-MS. Further, Rivera et al. [51] studied the effect of
ionization of carotenes, oxygenated carotenoids using ESI, APCI and APPI and reported that
12 of the 16 carotenoids exhibited strongest signal strength with APCI.
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Furthermore, MS/MS is considered to be an efficient method for carotenoids identification
by the use of transitions through precursor and daughter ions. This approach is also suita-
ble for the determination of carotenoids with the same molecular mass such as structural
isomers. Prasain et al. [52] developed a sensitive and specific ESI-MS/MS method using
MRM for the detection of carotenoid oximes (zeaxanthin oxidation products) in a human
eye sample. Further, this provides invaluable information on the characterization and quan-
tification of carotenoids and their oxidized products formed during in vitro and in vivo
studies. Crupi et al. [41] investigated carotenoids in a typical wine grape variety by using
RP-HPLC-DAD-MS (ESI+) method. Due to an unusual ionization process, their mass spectra
of carotenoids comprised both protonated molecules and molecular ion radicals. Further,
they were subjected for the selective collision-induced dissociation (CID) to differentiate
structural and geometrical isomers such as lutein isomers (zeaxanthin, 9Z and 9′Z-lutein)
and a cis-isomer of β-carotene (9Z- β-carotene), 5,6-epoxy xanthophylls, violaxanthin, (9′Z)-
neoxanthin, lutein-5,6-epoxide and 5,8-epoxy xanthophylls diastereoisomers (neochrome,
auroxanthin, luteoxanthin, flavoxanthin, chrysanthemaxanthin). Kopec et al. [13] performed
HPLC-MS/MS using APCI−ve mode to separate and detect the apo-6′-, apo-8′-, apo-10′-,
apo-12′-, apo-14′- and apo-15′-lycopenal products formed by in vitro oxidation reaction. The
quantitative analysis of carotenoids and other fat-soluble compounds performed simultane-
ously on a C30 column and detected by APCI-MS/MS with operation of selected reaction
monitoring (SRM) mode. Also, this method calibrated to shown a less variability in intra-
and inter-day precision analysis. Recently, ultrahigh performance liquid chromatography
(UPLC/UHPLC) has attracted much attention due to faster analysis and higher sensitivity
with 2 μm particle size stationary phases, thereby increasing column efficiency, decreasing
band broadening, and increasing resolution [4]. Granado-Lorencio et al. [53] assessed the
suitability of UHPLC for the simultaneous determination of biomarkers of vitamins includ-
ing vitamin A (retinol, retinyl esters) and major carotenoids in human serum. This method
allowed a better resolution for carotenes and xanthophylls isomers provides better sensitivi-
ty and reproducibility in peak area and retention time than the HPLC, with mean RSDs.
Rivera et al. [51] analyzed various carotenoids by UHPLC-MS/MS detection. Further, they
compared three different ionization techniques (ESI, APCI and APPI) to ionize the carote-
noids and concluded that APCI has a powerful technique to ionize carotenoids. They also
used dopants (acetone, toluene, anisole and chlorobenzene) that allowed the enhancement
of the carotenoid signals strength up to 178-fold. Delpino-Rius et al. [54] analyzed simulta-
neously epoxy carotenoids, hydroxyl carotenoids and carotenes in fresh homemade and in-
dustrially processed fruit products by UPLC. They identified 27 carotenoids eluted within
17 min; furthermore, this method allowed to differentiate the carotenoid profiles and 5,6- to
5,8-epoxycarotenoids. Separation of carotenoids on UHPLC columns illustrates less analysis
time compared to HPLC C30 column; however, the separation is better in C30 column.
Hence, there is a requirement for appropriate UHPLC column for rapid and sensitive anal-
ysis of carotenoids with better separation. Zhao et al. [55] developed a quick and simple
ultrahigh performance supercritical fluid chromatography-photodiode array detector
(UHPSFC-PDA) method and validated the determination of carotenoids in dietary supple-
ments using Acquity UPC2HSS column by gradient elution with carbon dioxide and sol-
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vent system. We have developed a rapid UPLC-MS/MS method for analysis of lycopene
isomers and their fragmentation pattern with CID and demonstrated the importance of ion
mobility to differentiate carotenoids geometrical isomers [56]. Dong et al. [57] characterized
and distinguished geometrical isomers of lycopene and β-carotene using ion mobility spec-
trometry. Raphael et al. [58] identified canthaxanthin oxidation products and compared the
similarity of β-carotene like oxidation products by using both LC–MS and GC–MS chroma-
tograms.
Figure 3. Hyphenated analytical techniques for the characterization of carotenoids and their metabolites.
The details of these techniques are discussed in Section 4.
Apart from these, Orbitrap MS a high-resolution mass spectrometry was also exploited for
carotenoids analysis to generate mass spectra with a resolving power up to 100,000 at full-
width half-maximum and mass accuracies within two parts per million (ppm). Due to its high
mass resolution and exact mass screening detectors, probable molecular formulae of the ions
and fragments were elucidated [59]. In continuation, Van Meulebroek et al. [60] developed a
full-scan high-resolution Orbitrap MS method enabling the metabolomic screening for
carotenoids in tomato fruit tissue. The validation demonstrated the excellent performance in
terms of linearity, repeatability and higher range of mean corrected recovery. Additionally, a
well-established detection technique, that is, MS/MS and ultraviolet-visible spectroscopy
photodiode array, indicated superior performance of high-resolution Orbitrap MS (with limits
of detection ranging from 1.0 to 3.8 pg μL−1). Contemporarily, 2D-LC and multi-dimensional
chromatography have emerged as a tool for carotenoid analysis. This provides an excellent
separation and resolution for analysis of complex matrices. In this regard, Cacciola, et al. [61]
developed and applied a comprehensive normal-phase × reversed-phase liquid chromatogra-
phy (NP-LC × RP-LC) system for analysis of the intact carotenoid composition of red chili
peppers, with photodiode array and mass spectrometry detection. A total of 33 compounds
separated into 10 diverse chemical classes in the 2-D space and identified by accurate IT-TOF
(ion trap-time of flight) MS. Apart from these, the robust technique LC-NMR offers 1-D and
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2-D NMR spectra for the components separated by HPLC. Recently, LC-NMR is used because
of improved sensitivity due to higher magnetic fields. Further, NMR provides information
about conformational geometry for structural elucidation. LC-NMR is established as a method
of analyzing major carotenoids and metabolites in food and biological samples [62]. The NMR
studies on carotenoids metabolites are scanty due to quantitative limitations. Therefore, LC-
MS-APCI studies are widely used in the characterization of carotenoids metabolites or
oxidative cleavage products. The approach of LC-MS techniques and ionization modes for
characterization of carotenoids and their metabolites are shown in Figure 3.
Even advancement in hyphenated analytical techniques and inconsistency of results may arise
due to several pre-chromatographic (samples or tissues, the nature of carotenoids, sample
preparation, incomplete extraction, solvent incompatibility, isomerization/oxidation, physical
losses of carotenoids/metabolites and its accountability) and post-chromatographic (low
recovery, less stability, inaccurate method validation, co-elution, unavailability of standards,
selection of improper mode of ionization, carotenoid/metabolites with same molecular mass)
errors in the carotenoids and their metabolites analysis [4]. The qualitative and quantitative
analyses of carotenoids need a proper method validation as per the ICH (International Council
on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human
Use) and IUPAC (International Union of Pure and Applied Chemistry) guidelines. The
method validation mainly comprises of precision, specificity, LOD, LOQ, linearity, sensitivity,
range and robustness. Carotenoid standard curves prepared for subsequent quantitation by
HPLC–PDA. The amounts of carotenoids calculated based on the regression equations. The
LOD and LOQ calculated for each standard on the basis of the signal-to-noise ratio (3:1 for
LOD and 10:1 for LOQ). LOD is the amount that resulted in a peak with a height three times
that of the baseline noise, respectively, and the LOQ determined as lowest injected amount
which could be quantifiable reproducibility (RSD ≤ 5%). The precision evaluated by the
relative coefficient of variation (%). The inter-and intra-day relative standard deviations (RSD)
for retention times of individual carotenoid are considered for standard concentration to check
the reproducibility of the method. The accuracy of the extraction method is assessed by
determining recovery of carotenoids with a mean value, respectively.
5. Biofunctionality of hydrocarbon carotenoid metabolites
β-Carotene is one of the most potent vitamin A precursor among other provitamin A
carotenoids (α-carotene, β-cryptoxanthin and γ-carotene). Chemically, vitamin A refers to all
isoprenoid compounds that possess the biological activity of all-trans-retinol. The parent
structure of most retinoids contains a substituted β-ionone ring with a side chain of three
isoprenoid units linked at the 6-position of the β-ionone ring. Retinol plays a role in vision,
differentiation and proliferation of a wide range of epithelial cells, bone growth, reproduction
and embryonic development. β-Carotene conversion to retinal, retinoic acid and other active
forms of the vitamin A family is well documented. Retinoic acids serve as ligands for nuclear
retinoic acid receptors (RARs), namely RXR and RAR, mediate vitamin A dependent activities.
Several studies have reported the biological properties of β-apocarotenoids. Zile et al. [63]
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demonstrated that retinol β-D-glucuronide (a metabolite of vitamin A) could arrest HL-60 cell
proliferation and induces differentiation into mature granulocytes; it may act by itself or by
being hydrolyzed to retinoic acid. Others have reported that β-carotene cleavage products, such
as β-apo-14′-carotenoic acid, stimulate the differentiation of U937 leukemia cells, and β-apo-12′-
carotenoic acid inhibits the proliferation of HL-60 cells [64, 65]. Hu et al. [66] characterized a
polar oxidation product of β-carotene 5,8-endoperoxy-2,3-dihydro-β-apocarotene-13-one and
demonstrated the inhibition of cell growth and cholesterol synthesis in MCF-7 cells. Kawada
et al. [67] suggested that the inhibitory action of adipocyte differentiation by carotenoids and
retinoids exhibited through the RAR upregulation and the suppression of PPARγ. Tibaduiza
et al. [68] tested the effect of synthetic eccentric cleavage products of β-carotene such as β-
apocarotenoid acids, including β-apo-8′-, β-apo-10′-, β-apo-12′- and β-apo-14′-carotenoic acid
on the growth of the human breast cancer cells. Further, they observed β-apo-14′ and β-apo-12′-
carotenoic acid significantly inhibited MCF-7 growth, and only β-apo-14′-carotenoic acid
inhibited Hs578T growth. Further, they observed none of these treatments inhibited the growth
of MDA-MB-231 cells. Also, authors concluded that apocarotenoid acids exhibit antiprolifer-
ative effects by downregulation of cell cycle regulatory proteins and inhibition of AP-1
transcriptional activity. Rühl et al. [69] also reported that β-carotene is involved in activation
of human pregnane receptor (PXR) a ligand-activated transcription factors involved in
xenobiotic detoxification in the liver. Ziouzenkova et al. [70] demonstrated that β-apo-14′-
carotenal, but not other structurally related apo-carotenals, represses peroxisome proliferator-
activated receptors (PPAR) and RXR activation. Eroglu et al. [71] demonstrated that none of
the β-apocarotenoids significantly activated RARs. However, β-apo-14′-carotenal, β-apo-14′-
carotenoic acid and β-apo-13-carotenone antagonized ATRA-induced transactivation of RARs.
Lycopene is another non-provitamin A hydrocarbon carotenoid present in human serum and
tissues. Recently, lycopene has attracted much attention due to its association with a decreased
risk of certain cancers, cardiovascular diseases and other chronic problems [72]. Several studies
from in vivo and in vitro suggest that lycopene induces apoptosis in cancer cells [73–75].
Structurally, lycopene consists of open-polyene chain lacking the β-ionone ring compared to
β-carotene and share a same molecular mass and chemical formula. Even though the metab-
olism of β-carotene extensively studied, the metabolism and biological activities of lycopene
are not detailed. Several studies support the concept that biological activities of lycopene are
mediated by its oxidative products/cleavage products [76–78]. The characterization of BCO II
enzyme has demonstrated that this enzyme can catalyze the eccentric cleavage of lycopene to
form apo-10′-lycopenoids [14]. Several lycopene metabolites have been identified in vivo and
in vitro [9, 13, 15, 35, 79], but their biological activities and mechanism of action need elucida-
tion. The discovery of various oxidation products or metabolites of carotenoids has questioned
the active role of them compared to intact carotenoid molecules in combating various diseases.
However, metabolites or oxidative products of LYC on health benefits are warranted. Nara et
al. [80] have demonstrated that autoxidation mixtures of LYC inhibited the HL-60 cell growth
effectively than LYC. Similarly, Zhang et al. [81] identified a cleavage product of LYC (E, E,
E)-4-methyl-8-oxo-2,4,6-nonatrienal and evaluated its apoptosis-inducing activity in HL-60
cells. Consequently, Aust et al. [38] reported the role of LYC degraded products in enhancing
cell communication and cell signaling. Lian et al. [5] demonstrated that apo-10′-lycopenoic
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acid is a biologically active metabolite of lycopene with potential chemopreventive agent
against lung tumorigenesis. Ford et al. [82] demonstrated that lycopene and apo-12′-lycopenal
reduce the proliferation of prostate cancer cells. In the recent study, apo-10′-lycopenoic acid
led to the increase in SIRT1 (Sirtuin 1) enzyme activity by treatment with this metabolite in
mice, resulting in prevention of fatty liver [83]. Due to its high antioxidant activity, lycopene
is more unstable and needs more advanced analytical techniques to identify and characterize
lycopene metabolites and their biological activities.
6. Biofunctionality of oxygenated carotenoid metabolites
Lutein and its isomer zeaxanthin are the two major carotenoids found in the human eye
associated with vision protective properties. Dietary consumption of lutein-rich fruits and
vegetables positively associated in decreasing AMD and cataract [8, 17]. Although conver-
sions of β-carotene to retinoids documented in animals and humans, only little is known
about the metabolism of xanthophyll carotenoids. In general, carotenoid metabolites are
involved in chemoprevention of cancer [6]. Lutein metabolites such as 3′-epilutein, 3′-oxo-
lutein, 3′-dehydrolutein, meso-zeaxanthin, methoxy-zeaxanthin, oxime derivatives of 3-hy-
droxy-β-ionone and 3-hydroxy-14-apocarotenal reported in human tissues and serum [9,
43, 52]. Characterization of these lutein and zeaxanthin metabolites in vitro and in vivo is
warranted to address their biological functions. The health benefit of these metabolites is
not detailed. The oxidized lutein may be highly reactive when combined with similar re-
active oxygen species and presumed to enhance antioxidant property [6], but the mecha-
nism of action of these xanthophylls (lutein) metabolites remains unanswered. Several
noteworthy studies have explored lutein metabolites in vivo [9, 18, 43, 44, 52]. However,
mechanism of action and other functional aspects of these metabolites/oxidative cleavage
products need further research. We reported the possible protective effect of lutein oxida-
tion products in cervical cancer cell lines [84]. Further, we also elucidated the formation of
lutein oxidation products mediated through peroxyl radicals and screened the antioxidant
and cytotoxic effects of oxidized lutein on HeLa cancer cells [6]. Previously, we identified
the apocarotenals, diepoxides and other oxidative degradation products of lutein in liver.
Further, we presumed that these products are formed ay due to the peroxyl radical-medi-
ated oxidation in the body [6, 44]. These results are significant in chain breaking peroxyl
radical or quenching of singlet oxygen. Furthermore, the existence of these oxidized mole-
cules in vivo is important in free radical chemistry and oxidative stress [85]. Possibly, oxi-
dized lutein may reduce the cancer cells viability through induction of apoptosis. Further,
result from our study demonstrated the inhibitory effect of these compounds on cancer
cell growth, which may be due to the effect on signaling pathway involved in apoptosis.
The biological activity of intact lutein may be different than its metabolites. Hence, it is
important to address that the beneficial role of lutein and zeaxanthin in delaying and pos-
sibly protecting against ascribed chronic diseases may be due to their metabolites. In the
case of other oxygenated carotenoids, such as astaxanthin, Wolz et al. [24] identified the
metabolized products such as 3-hydroxy-4-oxo-β-ionone and 3-hydroxy-4-oxo-7,8-dihydro-
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β-ionone in primary rat hepatocytes. Later, Kistler et al. [25] reported four radiolabeled
metabolites of astaxanthin including 3-hydroxy-4-oxo-β-ionol, 3-hydroxy-4-oxo-β-ionone,
3-hydroxy-4-oxo-7,8-dihydro-β-ionol and 3-hydroxy-4-oxo-7,8-dihydro-β-ionone in human
and primary human hepatocytes. Further, they demonstrated that incubation of astaxan-
thin with microsomes from liver containing detoxifying enzymes did not generate astax-
anthin metabolites. Sangeetha and Baskaran [86] hypothesized that astaxanthin might be
converted into retinol via β-carotene in retinol-deficient rats. However, the formation of
astaxanthin metabolites and their biological functions is not detailed. Further, studies re-
lated to astaxanthin metabolites and their biological functions are not detailed and ex-
plored.
Fucoxanthin is a major epoxy carotenoid found in the marine source (seaweeds) and explored
for its anticancer, anti-allergic and anti-obese activities [87, 88]. Dietary fucoxanthin is metab-
olized to fucoxanthinol in the gastrointestinal tract by digestive enzymes, and further, it is
converted to amarouciaxanthin in liver [23]. The bioactivity of fucoxanthin is attributed to its
metabolites fucoxanthinol and amarouciaxanthin A. There are reports demonstrated that
fucoxanthinol is effective and plays an important role in health benefits than intact fucoxan-
thin [89, 90]. Anti-proliferative and cancer preventing influences of fucoxanthin and fucoxan-
thinol are mediated through different signaling pathways [90]. Also, others have reported
fucoxanthin, and its metabolites regulate adipogenic gene expression and inhibit the adipocyte
differentiation of 3T3-L1 cells through downregulation of PPARγ. The suppressive effect of
fucoxanthinol is superior on adipocyte differentiation than its parent molecule [91]. In MDA-
MB-231 cells, fucoxanthinol reduced nuclear levels of NF-κB members and indicated an
effective for the treatment and/or prevention of breast cancer [89]. However, there are no much
reports on epoxy carotenoids identified in blood and tissues and may be due to the less dietary
importance. This is an active area of research and deserves further study. The overview of
biofunctionality of carotenoid cleavage products/metabolites is shown in Table 1.
Carotenoid Metabolites identified Bio-functionality of carotenoid metabolites References
Lycopene Oxidation products of lycopene Inhibits the growth of HL-60 human
promyelocytic leukemia cells
[80]
Acyclo retinoic acid Activates RAR to inhibit mammary cancer cells
growth
[92]
2,7,11-Trimethyl-
tetradecahexaene-1,14-dial
Enhance gap-junction communication [38]
(E,E,E)-4-methyl-8-oxo-2,4,6-
nonatrienal (MON)
Induce apoptosis by downregulation of Bcl-2
and Bcl-XL, and activated caspase cascades in
HL-60 cells
[81]
Apo-10′-lycopenoic acid Chemopreventive effect on lung carcinogenesis [5]
Apo-12′-lycopenal Reduced androgen-independent prostate cancer
cells
[82]
Apo-10′-lycopenoic acid Influence on SIRT1 enzyme activity and
prevention of fatty liver
[83]
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Carotenoid Metabolites identified Bio-functionality of carotenoid metabolites References
β-Carotene 5,8-Endoperoxy-2,3-dihydro-β-
apocarotene-13-one
Inhibits cell growth and cholesterol synthesis in
MCF-7 cells
[66]
5,6-Monoepoxide Greater differentiation-inducing activity than β-
carotene toward NB4 human leukemia
cells
[93]
Retinoyl β-D-glucuronide Arrest HL-60 cell proliferation and induce their
differentiation into mature granulocytes
[63]
β-Apo-14′-carotenoic acid Stimulates the differentiation of U937 leukemia
cells
[64]
β-Apo-12′-carotenoic acid Inhibits the proliferation of HL-60 cells [65]
Retinoids Inhibits adipocyte differentiation through RAR
upregulation and suppression of PPARγ
[67]
β-Apo-14′ and β-apo-12′-carotenoic
acid
Inhibits MCF-7 growth, and Hs578T growth [68]
β-Apo-14′-carotenal Represses PPAR and RXR activation [70]
β-Apo-14′-carotenal, β-apo-14′-
carotenoic acid, and β-apo-13-
carotenone
Antagonized ATRA-induced transactivation of
RARs
[71]
Lutein Photodegraded and peroxyl
mediated lutein oxidized
products
Higher antioxidant and cytotoxic effects in HeLa
cells
[6, 84]
Fucoxanthin Fucoxanthinol and
amarouciaxanthin A
Anti-proliferative effect on human prostate
cancer cells MCF-7 and MDA-MB-231 cells
[23]
[89]
Halocynthiaxanthin and
fucoxanthinol
Induces apoptosis in human leukemia, breast
and colon cancer cells
[94]
Fucoxanthinol Fucoxanthin metabolites reduced the growth
of primary effusion lymphoma tumor cells
[95]
Canthaxanthin 4-Oxoretinoic acid Induction of gap junctional communication in
murine fibroblasts
[96]
Table 1. Biofunctionality of carotenoid cleavage products/metabolites.
7. Conclusion
In concern to the application of analytical techniques in carotenoid, research needs a more
sophisticated instrumentation to increase sensitivity, precision, specificity and speed of
analysis. The increase in analytical hyphenation considered as cutting edge with multi-
dimensional or techniques that may support to decipher the carotenoids found in natural
sources and their effects on human health. Further, metabolomics corresponds to prevailing
analytical platforms to obtain detailed and complete information on the composition of food
components and their existence in biological entities. Further, the target in carotenoid/
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metabolites analysis is to understand the role of these compounds at the molecular levels
(i.e.,their interaction with genes and their subsequent effect on proteins and metabolites). This
information will provide a rational design of strategies to manipulate cell functions through
diet/nutraceuticals, which is expected to have an extraordinary impact on human health. The
development of the framework in genomics, transcriptomics, proteomics and metabolomics
has given rise to opportunities for increasing our understanding of different issues that can be
addressed by profiling carotenoid metabolites.
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